113 related articles for article (PubMed ID: 1544846)
21. The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects.
Yamagata M; Tannock IF
Br J Cancer; 1996 Jun; 73(11):1328-34. PubMed ID: 8645575
[TBL] [Abstract][Full Text] [Related]
22. Influence of pH on the cytotoxic activity of chlorambucil.
Brophy GT; Sladek NE
Biochem Pharmacol; 1983 Jan; 32(1):79-84. PubMed ID: 6830621
[TBL] [Abstract][Full Text] [Related]
23. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics.
Kozin SV; Shkarin P; Gerweck LE
Cancer Res; 2001 Jun; 61(12):4740-3. PubMed ID: 11406545
[TBL] [Abstract][Full Text] [Related]
24. Effects of oxygenation and pH on tumor cell response to alkylating chemotherapy.
Siemann DW; Chapman M; Beikirch A
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):287-9. PubMed ID: 1991690
[TBL] [Abstract][Full Text] [Related]
25. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
Herman TS; Teicher BA; Collins LS
Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
[TBL] [Abstract][Full Text] [Related]
26. Hydralazine does not increase hypoxia in tumors growing in preirradiated tissue.
Lemmon MJ; Brown JM
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1435-40. PubMed ID: 1938551
[TBL] [Abstract][Full Text] [Related]
27. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
Lee J; Siemann DW; Koch CJ; Lord EM
Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Ballinger JR; Kee JW; Rauth AM
J Nucl Med; 1996 Jun; 37(6):1023-31. PubMed ID: 8683295
[TBL] [Abstract][Full Text] [Related]
29. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Herman TS; Teicher BA; Coleman CN
Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
[TBL] [Abstract][Full Text] [Related]
30. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential.
Young SD; Hill RP
J Natl Cancer Inst; 1990 Mar; 82(5):371-80. PubMed ID: 2304086
[TBL] [Abstract][Full Text] [Related]
31. Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors.
Rotin D; Robinson B; Tannock IF
Cancer Res; 1986 Jun; 46(6):2821-6. PubMed ID: 3698008
[TBL] [Abstract][Full Text] [Related]
32. Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo.
Teicher BA; Herman TS; Kaufmann ME
Radiat Res; 1989 Jul; 119(1):134-44. PubMed ID: 2756104
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity of RSU 1069 in spheroids and murine tumors.
Olive PL; Durand RE; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1361-6. PubMed ID: 3624045
[TBL] [Abstract][Full Text] [Related]
34. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
Begleiter A; Leith MK
Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
[TBL] [Abstract][Full Text] [Related]
35. Assessing pH and oxygenation in cryotherapy-induced cytotoxicity and tissue response to freezing.
Griffin RJ; Williams BW; Roberts KP; Swanlund DJ; Bischof JC
Technol Cancer Res Treat; 2004 Jun; 3(3):245-51. PubMed ID: 15161317
[TBL] [Abstract][Full Text] [Related]
36. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia and acidity increase the cytotoxicity of mitomycin C and carboquone to human tumor cells in vitro.
Kohnoe S; Emi Y; Takahashi I; Yoshida M; Maehara Y; Sugimachi K
Anticancer Res; 1991; 11(4):1401-4. PubMed ID: 1746896
[TBL] [Abstract][Full Text] [Related]
38. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
[TBL] [Abstract][Full Text] [Related]
39. Modulation of tumor hypoxia by conventional chemotherapeutic agents.
Durand RE; LePard NE
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):481-6. PubMed ID: 8005803
[TBL] [Abstract][Full Text] [Related]
40. DNA cross-links in human tumor cells exposed to the prodrug PR-104A: relationships to hypoxia, bioreductive metabolism, and cytotoxicity.
Singleton RS; Guise CP; Ferry DM; Pullen SM; Dorie MJ; Brown JM; Patterson AV; Wilson WR
Cancer Res; 2009 May; 69(9):3884-91. PubMed ID: 19366798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
